Page 1654 - Clinical Small Animal Internal Medicine

1592 Index

capnography incidence of cardiopulmonary signalment 119
VetBooks.ir head trauma 756, 757 monitoring during CPR 370 vertebral heart score 128–130,
systemic veins 121
arrest 365
cardiopulmonary
resuscitation 370–371
open cardiac massage 370–371
130, 131
respiratory monitoring in critical postresuscitation care 371 see also individual diseases
care 377 principles of CPR 365–366 carnitine 678–679
capsule endoscopy 531, 532 ventilation 367, 371 CARS see compensatory
CAR see cortisol‐to‐ACTH ratio cardiovascular disease (CVD) antiinflammatory response
carbamate toxicity 808 119–125 syndrome
carbapenem‐resistant abdominal distension 121 case–control studies 16, 18, 21–23
Enterobacteriaceae (CRE) 1059 advanced ultrasound techniques castration 1312, 1314
carbapenems 1045 152, 161–162 cataracts 95–96, 95
carbohydrate metabolism 650 auscultation 122–124, 122, catecholamines
carcinoma 124–125 endocrinology 30
male reproductive system cardiac radiography 127–134 hypothermia 432
tumors 1312 case history and owner trauma and burns 447–448
mammary cancer 1322–1323 complaints 120–121 cathartics 443
nonmelanoma skin common abnormal cardiac catheters and catheterization
cancers 1354–1355 radiographic patterns 130–132, constrictive pericarditis 284–285
carcinoma in situ 1288 133, 134–139 fluid therapy 355–356
cardiac cachexia 261 conventional Doppler mechanical ventilation 400
cardiac neoplasia 1271–1275 echocardiography 137–151, nocosomial and multidrug‐resistant
diagnosis 1272–1273 152–160 infections 1058
epidemiology 1271–1272 conventional echocardiography urethral obstruction 1111–1113,
etiology/pathophysiology 1271 134–137, 140–144, 146–150, 150 1113–1114, 1117
history and clinical signs 1272 critical care setting 349 cat scratch disease (CSD) 924
prognosis 1274–1275 cyanosis 121 caudal vena cava (CVC) 671, 671
signalment 1272 diagnostic imaging 127–164 caval syndrome 414, 420
treatment 1273–1274 dyspnea, tachypnea, and cough 120 CAV/CAV‐2 see canine adenovirus
cardiac output (CO) 403–405, evaluation of fluid cavernous sinus syndrome 827–828
407–408, 413–414, 417 accumulation 122 CBD see common bile duct
cardiac troponin (cTn) 318–319 exercise intolerance, weakness, CBF see cerebral blood flow
cardiogenic shock 413–420 wasting, and syncope 120–121 CCB see calcium channel blockers;
diagnosis 416–417 generalized or localized heart canine chronic bronchitis
epidemiology 414–415 enlargement 133 CCECAI see Canine Chronic
forward and backward failure 413 left atrial enlargement 130, Enteropathy Clinical Activity Index
history and clinical signs 415–416 134–137 CDC see Centers for Disease Control
pathophysiology 413–414 left‐sided congestive heart and Prevention
prognosis 420 failure 131–132, 134, 136–137 CDI see central diabetes insipidus
signalment 415 left ventricular enlargement 130, CDV see canine distemper virus
treatment 417–420 134–135, 137 CDVD see chronic degenerative
cardiomegaly 249 mucous membranes 121 valvular disease
cardiopulmonary arrest (CPA) 365, normal thoracic radiography CE see chronic enteropathies; cranberry
366, 370, 417–418 127–130, 128–130, 128, 131, 132 extract
cardiopulmonary resuscitation palpation of the precordium cecal intussusception 504, 504
(CPR) 365–371 122, 122 cell death 1206–1207
advanced life support 367–369 peripheral arterial cell separator machines 1369
airway 367 pulsations 121–122 cell surface receptors 30–31
basic life support 366–367 physical examination 121–125 cellular energetics 1209–1210
chest compressions 366–367 plasma cell disorders 1242 cellular transplantation therapy 746
critical care setting 347, 348 respiratory auscultation 124–125 cellulitis 934
defibrillation 369–370 right‐sided congestive heart Center for Food Security and Public
diagnosing cardiopulmonary failure 132 Health 1065
arrest 366 right ventricular enlargement Centers for Disease Control and
discontinuing CPR 371 132, 134, 138 Prevention (CDC)